Gautier B - Search Results

1

In vivo real-time dynamics of ATP and ROS production in axonal mitochondria show decoupling in mouse models of peripheral neuropathies.

van Hameren G, Campbell G, Deck M, Berthelot J, Gautier B, Quintana P, Chrast R, Tricaud N. van Hameren G, et al. Among authors: gautier b. Acta Neuropathol Commun. 2019 Jun 11;7(1):86. doi: 10.1186/s40478-019-0740-4. Acta Neuropathol Commun. 2019. PMID: 31186069 Free PMC article.

2

AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A.

Gautier B, Hajjar H, Soares S, Berthelot J, Deck M, Abbou S, Campbell G, Ceprian M, Gonzalez S, Fovet CM, Schütza V, Jouvenel A, Rivat C, Zerah M, François V, Le Guiner C, Aubourg P, Fledrich R, Tricaud N. Gautier B, et al. Nat Commun. 2021 Apr 21;12(1):2356. doi: 10.1038/s41467-021-22593-3. Nat Commun. 2021. PMID: 33883545 Free PMC article.

3

Traumatic and Diabetic Schwann Cell Demyelination Is Triggered by a Transient Mitochondrial Calcium Release through Voltage Dependent Anion Channel 1.

Tricaud N, Gautier B, Berthelot J, Gonzalez S, Van Hameren G. Tricaud N, et al. Among authors: gautier b. Biomedicines. 2022 Jun 19;10(6):1447. doi: 10.3390/biomedicines10061447. Biomedicines. 2022. PMID: 35740468 Free PMC article.

4

Physiology of PNS axons relies on glycolytic metabolism in myelinating Schwann cells.

Deck M, Van Hameren G, Campbell G, Bernard-Marissal N, Devaux J, Berthelot J, Lattard A, Médard JJ, Gautier B, Guelfi S, Abbou S, Quintana P, Chao de la Barca JM, Reynier P, Lenaers G, Chrast R, Tricaud N. Deck M, et al. Among authors: gautier b. PLoS One. 2022 Oct 4;17(10):e0272097. doi: 10.1371/journal.pone.0272097. eCollection 2022. PLoS One. 2022. PMID: 36194565 Free PMC article.

5

Mapping the N-Terminal Hexokinase-I Binding Site onto Voltage-Dependent Anion Channel-1 To Block Peripheral Nerve Demyelination.

Gautier B, Forêt Jacquard M, Guelfi S, Abbou S, Gonzalez E, Berthelot J, Boukhaddaoui H, Lebrun A, Legrand B, Tricaud N, Inguimbert N. Gautier B, et al. J Med Chem. 2022 Sep 8;65(17):11633-11647. doi: 10.1021/acs.jmedchem.2c00411. Epub 2022 Aug 19. J Med Chem. 2022. PMID: 35984330

6

Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.

Zerah M, Piguet F, Colle MA, Raoul S, Deschamps JY, Deniaud J, Gautier B, Toulgoat F, Bieche I, Laurendeau I, Sondhi D, Souweidane MM, Cartier-Lacave N, Moullier P, Crystal RG, Roujeau T, Sevin C, Aubourg P. Zerah M, et al. Among authors: gautier b. Hum Gene Ther Clin Dev. 2015 Jun;26(2):113-24. doi: 10.1089/humc.2014.139. Epub 2015 Apr 28. Hum Gene Ther Clin Dev. 2015. PMID: 25758611 Clinical Trial.

7

Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.

Goncalves V, Gautier B, Coric P, Bouaziz S, Lenoir C, Garbay C, Vidal M, Inguimbert N. Goncalves V, et al. Among authors: gautier b. J Med Chem. 2007 Oct 18;50(21):5135-46. doi: 10.1021/jm0706970. Epub 2007 Sep 27. J Med Chem. 2007. PMID: 17900101

8

On-resin cyclization of peptide ligands of the Vascular Endothelial Growth Factor Receptor 1 by copper(I)-catalyzed 1,3-dipolar azide-alkyne cycloaddition.

Goncalves V, Gautier B, Regazzetti A, Coric P, Bouaziz S, Garbay C, Vidal M, Inguimbert N. Goncalves V, et al. Among authors: gautier b. Bioorg Med Chem Lett. 2007 Oct 15;17(20):5590-4. doi: 10.1016/j.bmcl.2007.07.087. Epub 2007 Aug 22. Bioorg Med Chem Lett. 2007. PMID: 17826090

9

Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist.

Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N. Gautier B, et al. J Med Chem. 2010 Jun 10;53(11):4428-40. doi: 10.1021/jm1002167. J Med Chem. 2010. PMID: 20462213

10

Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening.

Gautier B, Miteva MA, Goncalves V, Huguenot F, Coric P, Bouaziz S, Seijo B, Gaucher JF, Broutin I, Garbay C, Lesnard A, Rault S, Inguimbert N, Villoutreix BO, Vidal M. Gautier B, et al. Chem Biol. 2011 Dec 23;18(12):1631-9. doi: 10.1016/j.chembiol.2011.10.016. Chem Biol. 2011. PMID: 22195565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page